article thumbnail

Why Allergic Atopic Dermatitis is Underdiagnosed

MedEsthetics

The study in the Journal of the American Academy of Dermatology indicates that allergic contact dermatitis has similar symptoms and can be triggered by a range of substances, causing it to be underdiagnosed.

article thumbnail

Looking Ahead to Advancements in Vitiligo and Atopic Dermatitis

Dermatology Times

David Rosmarin, MD, shares key points from phase 3 data of ruxolitinib for vitiligo, as well as highlights the potential for targeting the STAT pathway in upcoming atopic dermatitis therapeutics.

article thumbnail

Don’t Forget to Address Autoimmune Comorbidities of Atopic Dermatitis

Dermatology Times

Jonathan Silverberg, MD, PhD, MPH, presented his tips for effectively treating atopic dermatitis without worsening autoimmune comorbidities.

article thumbnail

Exploring New Pathways in Atopic Dermatitis

Dermatology Times

Melinda Gooderham, MSc, MD, FRCPC, discusses potential new biologics for atopic dermatitis that target IL-22, IL-33, OX40, and more.

article thumbnail

Understanding The Heterogenous Nature of Atopic Dermatitis

Dermatology Times

Mark Lebwohl, MD, emphasizes the importance of considering various factors, including severity of itch and interference with sleep, when determining treatments for patients with atopic dermatitis, even with presentation may not include typical symptoms.

article thumbnail

Unraveling the Advancements in Seborrheic Dermatitis Treatment

Dermatology Times

Raj Chovatiya, MD, PhD, takes a deep dive in the challenges, solutions, and further research needed to treat seborrheic dermatitis.

article thumbnail

Dupilumab for Atopic Dermatitis: 7 Years Later

Dermatology Times

Today officially marks 7 years since the US FDA approved dupilumab for the treatment of atopic dermatitis. Here's a look back at its approval timeline and all it has accomplished in the dermatology world in the time since.